Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

The Angels Initiative

Stroke prevention


  Free Subscription

Articles published in Genes Chromosomes Cancer

Retrieve available abstracts of 19 articles:
HTML format

Single Articles

    December 2022
  1. DROBNA-SLEDZINSKA M, Mackowska-Maslak N, Jaksik R, Kosmalska M, et al
    Multiomics to investigate the mechanisms contributing to repression of PTPRC and SOCS2 in pediatric T-ALL: Focus on miR-363-3p and promoter methylation.
    Genes Chromosomes Cancer. 2022;61:720-733.
    PubMed     Abstract available

    November 2022
  2. KABURAGI T, Shiba N, Yamato G, Yoshida K, et al
    UBTF-Internal tandem duplication as a novel poor prognostic factor in pediatric acute myeloid leukemia.
    Genes Chromosomes Cancer. 2022 Nov 30. doi: 10.1002/gcc.23110.
    PubMed     Abstract available

    August 2022
  3. RUETHER C, Wuensch C, Randau G, Michgehl U, et al
    Design of a targeted next-generation DNA sequencing panel for pediatric T-cell lymphoblastic lymphoma to unravel biology and optimize treatment.
    Genes Chromosomes Cancer. 2022;61:459-470.
    PubMed     Abstract available

    July 2022
  4. LEE WY, Gutierrez-Lanz EA, Xiao H, McClintock D, et al
    ERG amplification is a secondary recurrent driver event in myeloid malignancy with complex karyotype and TP53 mutations.
    Genes Chromosomes Cancer. 2022;61:399-411.
    PubMed     Abstract available

    June 2022
  5. KOLEILAT A, Smadbeck JB, Zepeda C, Williamson CM, et al
    Characterization of Unusual iAMP21 B-lymphoblastic leukemia (iAMP21-ALL) from the Mayo Clinic and Children's Oncology Group.
    Genes Chromosomes Cancer. 2022 Jun 30. doi: 10.1002/gcc.23084.
    PubMed     Abstract available

    May 2022
  6. GAGNON MF, Berg HE, Meyer RG, Sukov WR, et al
    Typical, atypical and cryptic t(15;17)(q24;q21) (PML::RARA) observed in acute promyelocytic leukemia: a retrospective review of 831 patients with concurrent chromosome and PML::RARA dual-color dual-fusion FISH studies.
    Genes Chromosomes Cancer. 2022 May 31. doi: 10.1002/gcc.23070.
    PubMed     Abstract available

  7. JIANG F, Lang X, Chen N, Jin L, et al
    A Novel HNRNPH1::ERG Rearrangement in Aggressive Acute Myeloid Leukemia.
    Genes Chromosomes Cancer. 2022 May 3. doi: 10.1002/gcc.23051.
    PubMed     Abstract available

    March 2022
  8. GILLAM J, Catic A, Paulraj P, Dalton J, et al
    Acute megakaryoblastic leukemia with trisomy 3 and CBFA2T3::GLIS2: A case report.
    Genes Chromosomes Cancer. 2022 Mar 16. doi: 10.1002/gcc.23039.
    PubMed     Abstract available

  9. MACIEL ALT, Wolch K, Emerenciano M, Mansur MB, et al
    CRLF2 overexpression defines an immature-like subgroup which is rescued through restoration of the PRC2 function in T-cell precursor acute lymphoblastic leukemia.
    Genes Chromosomes Cancer. 2022 Mar 6. doi: 10.1002/gcc.23036.
    PubMed     Abstract available

    February 2022
  10. SIEGELE BJ, Stemmer-Rachamimov AO, Lilljebjorn H, Fioretos T, et al
    N-terminus DUX4-immunohistochemistry is a reliable methodology for the diagnosis of DUX4-fused B-lymphoblastic leukemia/lymphoma (N-terminus DUX4 IHC for DUX4-fused B-ALL).
    Genes Chromosomes Cancer. 2022 Feb 25. doi: 10.1002/gcc.23033.
    PubMed     Abstract available

  11. PATIL P, Hillebrecht S, Chteinberg E, Lopez C, et al
    T-cell prolymphocytic leukemia is associated with deregulation of oncogenic microRNAs on transcriptional and epigenetic level.
    Genes Chromosomes Cancer. 2022 Feb 25. doi: 10.1002/gcc.23034.
    PubMed     Abstract available

  12. GAO J, Gurbuxani S, Zak T, Kocherginsky M, et al
    Comparison of myeloid neoplasms with nonclassic 3q26.2/MECOM versus classic inv(3)/t(3;3) rearrangements reveals diverse clinicopathologic features, genetic profiles, and molecular mechanisms of MECOM activation.
    Genes Chromosomes Cancer. 2022;61:71-80.
    PubMed     Abstract available

    October 2021
  13. LESTRINGANT V, Duployez N, Penther D, Luquet I, et al
    Optical genome mapping, a promising alternative to gold standard cytogenetic approaches in a series of acute lymphoblastic leukemias.
    Genes Chromosomes Cancer. 2021;60:657-667.
    PubMed     Abstract available

    August 2021
  14. SALIM M, Heldt F, Thomay K, Lentes J, et al
    Cryptic TCF3 fusions in childhood leukemia - detection by RNA-sequencing.
    Genes Chromosomes Cancer. 2021 Aug 30. doi: 10.1002/gcc.22998.
    PubMed     Abstract available

  15. CHEN X, Yuan L, Zhou J, Wang F, et al
    Sustained remission after ruxolitinib and chimeric antigen receptor T-cell therapy bridged to a second allogeneic hematopoietic stem cell transplantation for relapsed Philadelphia chromosome-like B-cell precursor acute lymphoblastic leukemia with nove
    Genes Chromosomes Cancer. 2021 Aug 21. doi: 10.1002/gcc.22995.

  16. COSTA D, Granada I, Espinet B, Collado R, et al
    Balanced and unbalanced translocations in a multicentric series of 2,843 patients with chronic lymphocytic leukemia.
    Genes Chromosomes Cancer. 2021 Aug 19. doi: 10.1002/gcc.22994.
    PubMed     Abstract available

  17. ATKIN ND, Raimer HM, Wang Z, Zang C, et al
    Assessing acute myeloid leukemia susceptibility in rearrangement-driven patients by DNA breakage at topoisomerase II and CCCTC-binding factor/cohesin binding sites.
    Genes Chromosomes Cancer. 2021 Aug 18. doi: 10.1002/gcc.22993.
    PubMed     Abstract available

    May 2021
  18. CREASEY T, Enshaei A, Nebral K, Schwab C, et al
    Single nucleotide polymorphism (SNP) array-based signature of low hypodiploidy in acute lymphoblastic leukemia.
    Genes Chromosomes Cancer. 2021 May 3. doi: 10.1002/gcc.22956.
    PubMed     Abstract available

    February 2021
  19. AYPAR U, Yao J, Londono DM, Khoobyar R, et al
    Rare and novel RUNX1 fusions in myeloid neoplasms: A single-institute experience.
    Genes Chromosomes Cancer. 2021;60:100-107.
    PubMed     Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Leukemia is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.